TITAN PHARMACEUTICALS INC Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Titan Pharmaceuticals Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q2 2024.
  • Titan Pharmaceuticals Inc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$19K, a 1050% decline year-over-year.
  • Titan Pharmaceuticals Inc Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $1.67M, a 2154% increase year-over-year.
  • Titan Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2023 was $1.71M, a 5790% increase from 2022.
  • Titan Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2022 was $29K, a 95% decline from 2021.
  • Titan Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2021 was $578K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.67M -$19K -$21K -1050% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-15
Q1 2024 $1.69M $3K -$19K -86.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.71M -$39K -$84K -187% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $1.79M $1.72M +$1.72M +34360% Jul 1, 2023 Sep 30, 2023 10-K 2024-04-01
Q2 2023 $74K $2K +$22K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-15
Q1 2023 $52K $22K +$23K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $29K $45K +$96K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$67K $5K +$12K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$79K -$20K -$665K -103% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $586K -$1K +$8K +88.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $578K -$51K -$1.87M -103% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $2.45M -$7K +$252K +97.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.2M $645K +$902K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $1.29M -$9K +$1.35M +99.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$56K $1.82M +$1.97M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$2.02M -$259K -$1.34M -124% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$682K -$257K +$58K +18.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$740K -$1.36M -$1.13M -485% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $386K -$147K +$91K +38.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $295K $1.08M +$1.17M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$878K -$315K -$85K -37% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$793K -$232K -$34K -17.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$759K -$238K +$48K +16.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$807K -$93K +$28K +23.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$835K -$230K -$400K -235% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$435K -$198K -$630K -146% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $195K -$286K -$1.21M -131% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-02
Q3 2017 $1.41M -$121K -$117K -2925% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $1.53M $170K +$286K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $1.24M $432K +$447K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $792K $927K +$971K Oct 1, 2016 Dec 31, 2016 10-K/A 2019-04-02
Q3 2016 -$179K -$4K +$1K +20% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$180K -$116K +$1.07M +90.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$1.25M -$15K +$3.27M +99.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$4.52M -$44K -$824K -106% Oct 1, 2015 Dec 31, 2015 10-K 2018-04-02
Q3 2015 -$3.7M -$5K -$1.46M -100% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$2.24M -$1.19M -$897K -307% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$1.34M -$3.28M -$2.41M -277% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $1.07M $780K +$347K +80.1% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $725K $1.45M +$2.47M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$1.75M -$292K -$5.65M -105% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $3.9M -$870K -$6.7M -115% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 $10.6M $433K +$5.58M Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $5.02M -$1.02M -$968K -1976% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $5.99M $5.36M +$5.34M +35607% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 $651K $5.83M +$7.46M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$6.81M -$5.15M -$3.01M -141% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-31
Q3 2012 -$3.8M -$49K -$1.2M -104% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$2.6M $15K +$2.8M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$5.4M -$1.63M -$702K -75.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$4.7M -$2.13M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-31
Q3 2011 $1.15M +$1.4M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$2.79M -$2.67M -2224% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$929K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 -$249K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$120K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.